To use all functions of this page, please activate cookies in your browser.
My watch list
my.chemeurope.com
my.chemeurope.com
With an accout for my.chemeurope.com you can always see everything at a glance – and you can configure your own website and individual newsletter.
- My watch list
- My saved searches
- My saved topics
- My newsletter
8 Current news of Beckman Coulter
rss |
You can refine your search further. Select from the filter options on the left to narrow down your results. |
Beckman Coulter strenghtens laboratory automation business
Acquires of acoustic liquid handling company
01-Feb-2019
Beckman Coulter Life Sciences announced its acquisition of Labcyte, a privately held, acoustic liquid handling company based in San Jose, California. Labcyte is best known for its Echo® acoustic droplet ejection technology, which uses sound waves to transfer tiny amounts of liquid with ...
Danaher to Acquire Beckman Coulter, Inc. for $6.8 Billion
09-Feb-2011
Danaher Corporation announced that it has entered into a definitive merger agreement with Beckman Coulter, Inc. pursuant to which Danaher will acquire Beckman Coulter by making a cash tender offer to acquire all of the outstanding shares of common stock of Beckman Coulter at a purchase price ...
Beckman Coulter and Biosite Amend Definitive Acquisition Agreement
Strategic Rationale and Economics of Combination Support Increased Price of $90 per Biosite Share
04-May-2007
Beckman Coulter, Inc. announced that it has entered into a revised merger agreement with Biosite, Inc. Under the terms of the revised merger agreement, Beckman Coulter will acquire all of Biosite's outstanding common stock in a cash tender offer for $90.00 per share, or approximately $1.67 ...
Beckman Coulter to Acquire Biosite Incorporated
27-Mar-2007
Beckman Coulter, Inc. and Biosite(R) Incorporated announced that they have entered into a definitive merger agreement under which Beckman Coulter will acquire all of Biosite's outstanding common stock in a cash tender offer of $85.00 per share, or approximately $1.55 billion on a fully diluted ...
Beckman Coulter Licenses Roche`s Real Time PCR Patent Portfolio
24-Jul-2006
Beckman Coulter, Inc. has acquired an In Vitro Diagnostics product license to all real-time polymerase chain reaction (PCR) patents and pending patent applications owned or controlled by Roche Diagnostics, a division of F. Hoffmann-La Roche Ltd, Basel, Switzerland. Beckman Coulter will pay Roche ...
Beckman Coulter Announces Management Change
06-Mar-2006
Beckman Coulter, Inc. announced that James T. Glover, senior vice president and chief financial officer will retire from the company effective June 30, 2006. The company has started a search for Mr. Glover's replacement. "Beckman Coulter has undergone tremendous change in my 23 years with the ...
Beckman Coulter Names Scott Garrett CEO
26-Jan-2005
Beckman Coulter, Inc. announced that Scott Garrett has been named chief executive officer (CEO) of the corporation, effective February 21, 2005. Garrett, currently president and chief operating officer (COO), succeeds retiring CEO, John P. Wareham. Wareham will continue as chairman of the board ...
Beckman Coulter Signs Distribution Agreement with pION INC for Automated Drug Permeability Analysis
15-Dec-2004
Beckman Coulter, Inc. announced it has entered into a 5-year distribution agreement with pION INC of Woburn, Mass., to deliver a fully validated solution for the automation of in vitro drug permeability measurements. . "This agreement expands Beckman Coulter's drug discovery automation product ...
Page 1 From 1
